UBCS039 is primarily researched for its potential therapeutic applications in the field of neurodegenerative diseases, particularly those involving mitochondrial dysfunction. It has shown promise in enhancing mitochondrial activity and promoting cellular energy production, which is crucial in conditions like Parkinson's disease and Alzheimer's disease. Studies suggest that UBCS039 may help protect neurons from oxidative stress and improve overall neuronal health. Additionally, it is being explored for its role in modulating autophagy, a cellular process that removes damaged components, which could further support its use in treating age-related neurological disorders. Ongoing research aims to validate its efficacy and safety for clinical use.